TG Therapeutics said it is working to develop a subcutaneous (under-the-skin) version of relapsing MS therapy Briumvi.
Sales of the brand's scalp treatment are up by a huge 264% – but just why is scalp care so in focus right now?
While the salesman continued to reach out, the OP finally responded to one of his Teams calls—while sitting in an infusion room at his wife's oncology appointment. With his camera on, his wife visibly ...
The Lunar New Year, a cherished celebration marking the arrival of spring and ushering in the New Year in several cultures ...
AN INFLUENCER has revealed she’s spending a whopping £50,000 a MONTH in a bid to keep the ageing process at bay. Ju Isen, a ...
Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adjunctive therapy i) in the treatment of partial-onset seizures in adults with epilepsy, ii) in the treatment of ...
The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.
Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...
Caplin Point Laboratories has announced that its subsidiary, Caplin Steriles, has received final nod from United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application ...